Current status:
Cancelled Pre Market
Current status date:
2017-09-13
Product name:
PHL-NYSTATIN SUSPENSION 100000 UNIT/ML
DIN:
02260522
Electronic product monograph is not available
Company:
PHARMEL INC
6111, Avenue Royalmount, Suite 100
Montreal
Quebec
Canada
H4P 2T4
Dosage form(s):
Suspension
Route(s) of administration:
Oral
Number of active ingredient(s):
1
Schedule(s):
Prescription
Anatomical Therapeutic Chemical (ATC):
See footnote 4
A07AA02 NYSTATIN
List of active ingredient(s)
Active ingredient(s) |
Strength |
NYSTATIN
|
100000 UNIT / ML
|